KYAN Therapeutics logo

KYAN Therapeutics

Advanced AI for Faster, Safer Drug Development and Optimized Therapies

2-10 employees · est. 2014

VS
QuantHealth logo

QuantHealth

Accelerating drug development with AI-driven patient-centric medication simulations to enhance trial design and boost success rates.

11-50 employees · est. 2020

KYAN Therapeutics is the older company (2014 vs 2020); QuantHealth is the larger of the two.

Side-by-Side Comparison

KYAN Therapeutics QuantHealth
Founded
2014 older 2020
Headquarters
Not tracked yet Not tracked yet
Employees
2-10 11-50 larger
Industry
AI, Biopharma, Biotechnology AI, Pharmaceutical
Funding Stage
Seed Series A
Total Funding
$5.00M $17.00M
Funding Rounds
1 3
Services
Domain parking and registration Not tracked yet
Target Customers
Businesses seeking to park or register domain names Not tracked yet
Taxonomy
Advanced AI, Drug Development, Dosage Optimization, Proprietary Technology, Combination Therapies, Oncology, Infectious Diseases, Clinical-stage Company, Therapy Development, Efficacy And Safety, Disease Mechanism Agnostic, Indication Agnostic, Digital Healthcare, Personalized Medicine Drug Simulation, Bioinformatics, RWD/RWE, Computational Biology, Trial Simulation, Patient Centric Drug Development, In-Silico Medicine, Clinical Data Science, Health Informatics, Oncology, Auto-Immune, Respiratory, HemOnc, Drug R&D, Patient Outcomes
Website
kyantherapeutics.com quanthealth.ai
KYAN Therapeutics logo

About KYAN Therapeutics

KYAN Therapeutics, established in 2014, is a clinical-stage company at the intersection of AI and biopharma, focused on revolutionizing drug development through its proprietary artificial intelligence technology. The company aims to optimize therapy protocols, significantly accelerating the developm...

QuantHealth logo

About QuantHealth

QuantHealth, a 2020-founded startup, aims to revolutionize drug development with its AI-driven platform. The company's slogan "Accelerating drug development with AI-driven patient-centric medication simulations to enhance trial design and boost success rates" encapsulates their mission to enhance pa...

We will tell you when either one moves

BounceWatch watches KYAN Therapeutics and QuantHealth for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at KYAN Therapeutics and QuantHealth — by email.

Frequently Asked Questions

KYAN Therapeutics — Advanced AI for Faster, Safer Drug Development and Optimized Therapies. QuantHealth — Accelerating drug development with AI-driven patient-centric medication simulations to enhance trial design and boost success rates.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
KYAN Therapeutics has raised $5.00M while QuantHealth has raised $17.00M.
KYAN Therapeutics and QuantHealth operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare KYAN Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at KYAN Therapeutics on 15 Jun 2026, and QuantHealth on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy